Electrically enhanced drug delivery for the treatment of soft tissue sarcoma

Cancer

Volumn 85, Issue 2, 1999, Pages 409-417

  Hyacinthe, Micheline ^a   Jaroszeski, Mark J ^a   Dang, Vu V ^a   Coppola, Domenico ^b   Karl, Richard C ^a   Gilbert, Richard A ^c   Heller, Richard ^a,b,c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Bleo mycin; Chemotherapy; Electrochemotherapy; Electropermeabilization; Electroporation; Sarcoma

Indexed keywords

BLEOMYCIN; BLEOMYCIN SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; DRUG DELIVERY SYSTEM; ELECTROCHEMOTHERAPY; ELECTROPORATION; HISTOLOGY; INJECTION SITE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SOFT TISSUE SARCOMA; TUMOR VOLUME;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; DRUG DELIVERY SYSTEMS; ELECTROPORATION; HUMANS; MALE; NEOPLASM TRANSPLANTATION; RATS; RATS, NUDE; SARCOMA; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

EID: 0032939096     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990115)85:2<409::AID-CNCR19>3.0.CO;2-I     Document Type: Article

References (38)

1. Wingo PA, Tong T, Bolden S. Cancer Stat 1995;45:12.
2. Levine EA, Trippon M, Das Gupta TK. Preoperative multimodality treatment for soft-tissue sarcomas. Cancer 1993; 71:3685-9.
3. Yang JC, Glatstein EJ, Rosenberg SA, Antman KH. Sarcomas of soft tissues. In: Devita VT, Jr., Hellman S, Rosenberg SA, editors. Cancer. Principles and practice of oncology. 5th edition. Philadelphia: J.B. Lippincott Co., 1993:1437-88.
4. Lawrence W Jr. Operative management of soft-tissue sarcomas: impact of anatomic site. Semin Surg Oncol 1994;10: 340-6.
5. Yang JC, Rosenberg SA. Surgery for adult patients with soft tissue sarcomas. Semin Oncol 1989;16(4):289-96.
6. Pisters PWT, Harrison LB, Woodruff JM, Gaynor JJ, Brennan MF. A prospective randomized trial of adjuvant brachytherapy in the management of low-grade soft tissue sarcomas of the extremity and superficial trunk. J Clin Oncol 1994;12(6): 1150-5.
7. Rosenberg SA, Kent H, Costa J, Webber BL, Young R, Chabner B, et al. Prospective randomized evaluation of the role of limb-sparing surgery, radiation therapy, and adjuvant chemoimmunotherapy in the treatment of adult soft-tissue sarcomas. Surgery 1978;84(1):62-9.
8. Heller R, Jaroszeski MJ, Reintgen DS, Puleo CA, DeConti RC, Gilbert RA, et al. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 1998;83:148-157.
9. Heller R, Jaroszeski MJ, Glass LF, Messina JL, Rapaport DP, DeConti RC, et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 1996;77(5):964-71.
10. Rudolf Z, Stabuc B, Cemazar M, Miklavcic D, Vodovnik L, Sersa, G. Electrochemotherapy with bleomycin. The first clinical experience in malignant melanoma patients. Radiol Oncol 1995;29:229-35.
11. Glass LF, Fenske NA, Jaroszeski MJ, Perrott R, Harvey DT, Reintgen DS, et al. Bleomycin-mediated electrochemotherapy of basal cell carcinoma. J Am Acad Dermatol 1996; 34(1):82-6.
12. Mir LM, Belehradek M, Domenge C, Orlowski S, Poddevin J Jr., Schwab G, et al. Electrochemotherapy, a novel antitumor treatment: first clinical trial. C R Acad Sci III 1991;313:613-8.
13. Belehradek M, Domenge C, Luboinnski B, Orlowski S, Belehradek J, Mir LM. Electrochemotherapy, a new antitumor treatment. Cancer 1993;72(12):3694-700.
14. Domenge C, Orlowski S, Luboinski B, DeBaere T, Schwaab G, Belehradek J, Jr., et al. Antitumor electrochemotherapy. Cancer 1996;77(5):956-63.
15. Mir LM, Banoun H, Paoletti C. Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. Exp Cell Res 1988;175:15-25.
16. Orlowski S, Belehradek J Jr., Paoletti C, Mir LM. Transient electropermeabilization of cells in culture. Biochem Pharmacol 1988;37(24):4727-33.
17. Heller R, Jaroszeski M, Leo-Messina J, Perrott R, Van Voorhis N, Reintgen D, et al. Treatment of B16 melanoma with the combination of electroporation and chemotherapy. Bioelectrochem Bioenerget 1995;36:83-7.
18. Mir LM, Orlowski S, Belehradek J Jr., Paoletti C. Electrochemotherapy potentiation of antitumor effect of bleomycin by local electric pulses. Eur J Cancer 1991;27:68-72.
19. Sersa G, Cemazar M, Miklavcic D. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum (II) in mice. Cancer Res 1995;55:3450-5.
20. Kanesada H. Anticancer effect of high voltage pulses combined with concentration dependent anticancer drugs on lewis lung carcinoma, in vivo. J Jpn Soc Cancer Ther 1990; 25:2640-8.
21. Belehradek J Jr., Orlowski S, Poddevin B, Paoletti C, Mir LM. Electrochemotherapy of spontaneous mammary tumors in mice. Eur J Cancer 1991;27:73-6.
22. Okino M, Tomie H, Kanesada H, Marumoto M, Morita N, Esato K, et al. Induction of tumor specific selective toxicity in electrical impulse chemotherapy-analysis of dose response curve. Oncologia 1991;24:71-9.
23. Salford LG, Persson BRR, Brun A, Ceberg CP, Kongstad PCH, Mir LM. A new brain tumor therapy combining bleomycin with in vivo electropermeabilization. Biochem Biophys Res Commun 1993;194(2):938-43.
24. Heller R, Jaroszeski M, Messina J, Perrott R, Van Voorhis N, Gilbert R. Treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy. Melanoma Res 1997; 7:10-8.
25. Jaroszeski MJ, Messina J, Perrott R, Van Voorhis N, Gilbert R, Heller R. Effectiveness of treating B16 melanoma with multiple treatment electrochemotherapy. Melanoma Res 1996; 6:427-33.
26. Gilbert RA, Jaroszeski MJ, Heller R. Novel electrode designs for electrochemotherapy. Biochim Biophys Acta 1997;1334: 9-14.
27. Jaroszeski MJ, Gilbert RA, Heller R. In vivo antitumor effects of electrochemotherapy in a hepatoma model. Biochim Biophys Acta 1997;1334:15-8.
28. Hofmann GA, Dev SB, Nanda GS. Electrochemotherapy: transition from laboratory to the clinic. IEEE Eng Med Biol 1996;15:124-32.
29. Jaroszeski MJ, Gilbert R, Heller R. Electrochemotherapy: an emerging drug delivery method for the treatment of cancer. Adv Drug Delivery Rev 1997;26:185-97.
30. Mir LM, Orlowski S, Poddevin B, Belehradek J Jr. Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. Eur Cytokine Netw 1992;3(3):331-4.
31. Mir LM, Roth C, Orlowski S, Quintin-Colonna F, Fradelizi D, Belehradek J Jr., et al. Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J Immunol 1995;17:30-8.
32. Teissie J. Time course of electropermeabilization. In: Allen MJ, Cleary SF, Sowers AE, Shillady DD. Time course of electropermeabilization in Charge and Field Effects in Biosystems-3. Boston: Birkhauser, 1992:285-301.
33. Gehl J, Skovsgaard T, Mir LM. Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anticancer Drugs 1998;9:319-25.
34. Amato DA, Borden EC, Shiraki M, Enterline HT, Rosenbaum C, Davis HL, et al. Evaluation of Bleomycin, Chlorozotocin, MGBG, and Bruceantin in patients with advanced soft-tissue sarcoma, bone sarcomas, or mesothelioma. Invest New Drugs 1985;3:397-401.
35. McGrath DC, Sloan DA, Denady DE. Adjuvant therapy of soft-tissue sarcomas. Clin Plast Surg 1995;22:21-9.
36. Casper ES, Gaynor JJ, Harrison LB, Panicek DM, Hajdu SI, Brennan MF. Preoperative and postoperative adjuvant combination chemotherapy for adults with high grade soft tissue sarcoma. Cancer 1994;73(6):1644-51.
37. Wilson RE, Wood WC, Lerner HL, Antman K, Amato D, Corson JM, et al. Doxorubicin chemotherapy in the treatment of soft-tissue sarcoma. Combined results of two randomized trials. Arch Surg 1986;121:1354-9.
38. Tepper JE, Suit HD. Radiation therapy of soft tissue sarcomas. Cancer 1985;55:2273-7.